Real-time platelet P2Y(12) receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK/PD of clopidogrel therapy.
实时血小板 P2Y(12) 受体占有率作为一种有前景的药效学生物标志物,可以弥合氯吡格雷治疗的 PK/PD 之间的差距
期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2024.08.008
Li Haipeng, Gu Yueming, Zhao Yumeng, Xu Aiyun, Sun Dong, Gu Jingkai